Nutritional, Metabolic, Endocrine
Conditions
Interventions
Capsaicin group
Miconazole group
Sponsors
AsacPharma laboratories Cameroon
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All were patients with type 2 diabetes who had daily pain or painful paresthesias in a neuropathic or radiculopathic distribution, intensity between 4 and 7 on a visual analogic scale, interfering with daily activities, work or sleep for at least 3 months duration.
Exclusion criteria
Exclusion criteria: • History of allergies to any capsaicin product • Diabetic patients with other diagnosed etiology responsible for peripheral neuropathy such as hepatitis, AIDS, Nutritional deficiencies (folate, vitamin B12) • Presence of open skin lesions at the site of application of the study medication • Signs of infection on limbs or amputations • Pregnant or lactating females • Subjects with other topical medication at site of application of study cream. • All eligible patients who did not give their signed informed consent to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reduction in the mean pain score from baseline, as assessed by the Visual analogic scale (0-10 points). | — |
Secondary
| Measure | Time frame |
|---|---|
| the level of improvement in quality of life score after intervention. | — |
Countries
Cameroon
Contacts
Public ContactMesmin Dehayem
Doctor
Outcome results
None listed